| Literature DB >> 24376297 |
E DE Corso1, A Fiorita1, G Rizzotto2, G F Mennuni2, D Meucci1, M Giuliani1, M R Marchese1, L Levantesi3, G Della Marca2, G Paludetti1, E Scarano1.
Abstract
Nowadays, drug-induced sleep endoscopy (DISE) is performed widely and its validity and reliability has been demonstrated by several studies; in fact, it provides clinical information not available by routine clinical inspection alone. Its safety and utility are promising, but still needs to be improved to reach the level of excellence expected of gold standard tests used in clinical practice. Our study compares the results of clinical and diagnostic evaluation with those of sleep endoscopy, evaluating the correlation between clinical indexes of routine clinical diagnosis and sites of obstruction in terms of number of sites involved, entity of obstruction and pattern of closure. This study consists in a longitudinal prospective evaluation of 138 patients who successfully underwent sleep endoscopy at our institution. Patients were induced to sleep with a low dose of midazolam followed by titration with propofol. Sedation level was monitored using bispectral index monitoring. Our results suggest that the multilevel complete collapse was statistically significantly associated with higher apnoea hypopnea index values. By including partial sites of obstruction greater than 50%, our results also suggest that multilevel collapse remains statistically and significantly associated with higher apnoea hypopnoea index values. Analyzing BMI distribution based on number of sites with complete and partial obstruction there was no significant difference. Finally, analyzing Epworth Sleepiness Score distribution based on number of sites with complete obstruction, there was a statistically significant difference between patients with 3-4 sites of obstruction compared to those with two sites or uni-level obstruction. In conclusion, our data suggest that DISE is safe, easy to perform, valid and reliable, as previously reported. Furthermore, we found a good correlation between DISE findings and clinical characteristics such as AHI and EPS. Consequently, adequate assessment by DISE of all sites of obstruction is very important, not only in patients with low-moderate AHI and EPS, but also in patients with a high AHI or/and high EPS, in particular to plan multilevel surgery that in these latter situations is more demanding since success may be harder to achieve.Entities:
Keywords: AHI; BMI; Drug-induced sleep endoscopy; EPS; Obstructive sleep apnoea syndrome
Mesh:
Year: 2013 PMID: 24376297 PMCID: PMC3870452
Source DB: PubMed Journal: Acta Otorhinolaryngol Ital ISSN: 0392-100X Impact factor: 2.124
Patient distribution considering site of complete (100%) obstruction and AHI and BMI.
| Complete retro palatal collapse | Complete retro lingual collapse | Complete oro-hypopharyngeal lateral wall collapse | Complete laryngeal collapse | |
|---|---|---|---|---|
| 102 (73.9%) | 60 (43.47%) | 32 (23.18%) | 44 (31.88%) | |
| 42 (58.33%) | 14 (19.44%) | 4 (5.55%) | 18 (25%) | |
| 60 (90.90%) | 46 (69.69%) | 28 (42.42%) | 26 (39.39%) | |
| 82 (75.92%) | 42 (38.88%) | 22 (20.37%) | 36 (33.33%) | |
| 20 (66.66%) | 18 (60%) | 10 (33.33%) | 8 (26.66%) |
Patient distribution considering sites of partial (greater than 50%) obstruction and AHI and BMI.
| Partial retro palatal collapse | Partial retro lingual collapse | Partial oro-hypopharyngeal lateral wall collapse | Partial laryngeal collapse | |
|---|---|---|---|---|
| 34 (24.63%) | 48 (34.78%) | 52 (37.68%) | 36 (26.08%) | |
| 22 (30.55%) | 32 (44.44%) | 32 (44.44%) | 18 (25%) | |
| 10 (15.15%) | 14 (21.21%) | 22 (32.33%) | 18 (27.27%) | |
| 26 (24.07%) | 44 (40.74%) | 48 (44.44%) | 28 (25.92%) | |
| 6 (20%) | 4 (13.33%) | 6 (20%) | 8 (26.66%) |
Patient distribution based on number of complete sites of obstruction and AHI and BMI.
| 1 site | 2 sites | 3 sites | 4 sites | |
|---|---|---|---|---|
| 54 (39.13%) | 52 (37.68%) | 16 (11.59%) | 16 (11.59%) | |
| 38 (52.7%) | 22 (30.5%) | 4 (2.8%) | 0 | |
| 14 (9.24%) | 30 (45.45%) | 12 (18.18%) | 16 (24.24%) | |
| 50 (46.29%) | 40 (37.03%) | 8 (7.40%) | 12 (11.11%) | |
| 6 (20%) | 10 (33.33%) | 6 (20%) | 4 (13.33%) |
Patient distribution based on number of partial (greater than 50%) sites of obstruction and AHI and BMI.
| 1 site | 2 sites | 3 sites | 4 sites | |
|---|---|---|---|---|
| 6 (4.34%) | 42 (30.43%) | 30 (21.73%) | 58 (42.02%) | |
| 4 (5.5%) | 26 (36.11%) | 12 (16.66%) | 24 (33.33%) | |
| 2 (3.03%) | 16 (24.24%) | 18 (27.27%) | 34 (51.51%) | |
| 6 (5.55%) | 34 (31.48%) | 18 (16.66%) | 48 (44.44%) | |
| 0 (%) | 6 (20%) | 14 (46.66%) | 10 (33.33%) |
Distribution of patients based on patterns of obstruction for each site.
| Antero – posterior | Lateral | Concentric | ||||
|---|---|---|---|---|---|---|
| 18/138 (13.04%) | 40/138 (28.98%) | 6/138 (4.34%) | 40/138 (28.98%) | 28/138 (20.28%) | 42/138 (30.43%) | |
| / | / | 24/138 (17.39%) | 14/138 (10.14%) | / | / | |
| 48/138 (34.78%) | 60/138 (43.47%) | / | / | / | / | |
| 20/138 (14.49%) | 28/138 (20.28%) | 16/138 (11.59%) | 16/138 (11.59%) | / | / | |
Fig. 1.AHI distribution based on the number of sites of complete collapse (a) and complete plus partial collapses greater than 50% (b). The box plots show the median and inter-quartile range and the error bars show the 5th and 95th percentiles.
a. 1: one complete site of obstruction of 100%; 2: two complete sites of obstruction of 100%; 3: three complete sites of obstruction of 100%; 4: four complete sites of obstruction of 100%).
b. 1: one site of obstruction of 100% or > 50%; 2: two sites of obstruction of 100% and/or > 50%; 3: three sites of obstruction of 100% and/or > 50%; 4: four sites of obstruction of 100% and/or > 50%).
Fig. 2.BMI distribution based on the number of sites of complete collapse (a) and complete plus partial collapses greater than 50% (b). The box plots show the median and inter-quartile range and the error bars show the 5th and 95th percentiles.
a. 1: one complete site of obstruction of 100%; 2: two complete sites of obstruction of 100%; 3: three complete sites of obstruction of 100%; 4: four complete sites of obstruction of 100%).
b. 1: one site of obstruction at 100% or > 50%; 2: two sites of obstruction of 100% and/or > 50%; 3: three sites of obstruction of 100% and/or >5 0%; 4: four sites of obstruction of 100% and/or > 50%).
Fig. 3.Epworth Sleepiness Score distribution based on the number of sites of complete collapse. The box plots show the median and inter-quartile range and the error bars show the 5th and 95th percentiles.
1: one complete site of obstruction of 100%; 2: two complete sites of obstruction of 100%; 3: three complete sites of obstruction of 100%; 4: four complete sites of obstruction of 100%).
Fig. 4.AHI (a) and BMI (b) in patients with (1) or without (0) concentric complete oropharyngeal collapse.
Fig. 5.AHI in patients with (1) or without (0) laryngeal site collapse.
Distribution of patients based on treatment options chosen considering clinical information obtained during drug induced sleep endoscopy and subdivided based on AHI and BMI. In the last column, the number of cases referred to repeat polysomnography due to inconsistencies between DISE and AHI is reported.
| Oral device | Surgery | CPAP | Repeat PSNG | |
|---|---|---|---|---|
| All patients (n = 138) | 42 (30.43%) | 28 (20.28%) | 56 (40.57%) | 4 (2.89%) |
| AHI < 30 (n = 72) | 30 (41.66%) | 18 (25%) | 18 (25%) | 3 (4.16%) |
| AHI ≥ 30 (n = 66) | 14 (21.21%) | 12 (11.32%) | 38 (57.57%) | 1 (1.51%) |
| BMI < 30 (n = 108) | 34 (31.48%) | 26 (24.07%) | 44 (40.74%) | 2 (1.85%) |
| BMI ≥ 30 (n = 30) | 6 (20%) | 4 (13.33%) | 16 (53.33%) | 2 (6.66%) |